Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
26.03.24
/
50%
€17.20
Target price
26.03.25
€26.71
Performance (%)
-63.78%
Price
02.10.24
€6.31
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc. is performing very badly with a performance of -63.78%. This prediction currently runs until 26.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -3.131% | -3.131% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.63
12.07.24
12.07.24
€16.50
12.07.25
12.07.25
-41.39%
02.10.24
02.10.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.99
20.06.24
20.06.24
€21.44
20.06.25
20.06.25
-37.31%
02.10.24
02.10.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.59
01.05.24
01.05.24
€26.21
01.05.25
01.05.25
-49.87%
02.10.24
02.10.24